Skip to main content
Tulane Home Tulane Home

Tulane Cancer Center ~ Clinical Trials ~ Renal

ROCHE WO39210
A Phase III, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of Atezolizumab (Anti-PD-L1 Antibody) as Adjuvant Therapy in Patients with Renal Cell Carcinoma at High Risk of Developing Metastasis Following Nephrectomy
More Information